25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Adial Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyze Adial Pharmaceuticals Inc together

I guess you are interested in Adial Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Adial Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Adial Pharmaceuticals Inc

I send you an email if I find something interesting about Adial Pharmaceuticals Inc.

1. Quick Overview

1.1. Quick analysis of Adial Pharmaceuticals Inc (30 sec.)










1.2. What can you expect buying and holding a share of Adial Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.64
Expected worth in 1 year
$1.14
How sure are you?
44.4%

+ What do you gain per year?

Total Gains per Share
$0.50
Return On Investment
47.1%

For what price can you sell your share?

Current Price per Share
$1.07
Expected price per share
$0.93 - $1.92
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Adial Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)
$1.07
Intrinsic Value Per Share
$-16.46 - $-9.78
Total Value Per Share
$-15.83 - $-9.15

2.2. Growth of Adial Pharmaceuticals Inc (5 min.)




Is Adial Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$4m$3.2m$807k19.8%

How much money is Adial Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$7m-$12.7m$5.7m81.8%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Adial Pharmaceuticals Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#709 / 950

Most Revenue
#897 / 950

Most Profit
#490 / 950

Most Efficient
#265 / 950
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Adial Pharmaceuticals Inc?

Welcome investor! Adial Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Adial Pharmaceuticals Inc.

First you should know what it really means to hold a share of Adial Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Adial Pharmaceuticals Inc is $1.07. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Adial Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Adial Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.64. Based on the TTM, the Book Value Change Per Share is $0.13 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Adial Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.09-102.2%-1.09-102.2%-1.99-185.7%-1.83-171.1%-1.26-117.8%
Usd Book Value Change Per Share0.1311.8%0.1311.8%-0.04-3.4%-0.01-1.0%0.076.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.1311.8%0.1311.8%-0.04-3.4%-0.01-1.0%0.076.6%
Usd Price Per Share1.86-1.86-0.22-1.78-1.56-
Price to Earnings Ratio-1.70--1.70--0.11--1.10--0.92-
Price-to-Total Gains Ratio14.76-14.76--5.95--5.02--3.18-
Price to Book Ratio2.92-2.92-0.42-2.63-2.28-
Price-to-Total Gains Ratio14.76-14.76--5.95--5.02--3.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.07
Number of shares934
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.13-0.01
Usd Total Gains Per Share0.13-0.01
Gains per Quarter (934 shares)117.67-10.43
Gains per Year (934 shares)470.68-41.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
104714610-42-52
209419320-83-94
30141214030-125-136
40188318740-167-178
50235323450-209-220
60282428160-250-262
70329532870-292-304
80376537580-334-346
90423642290-376-388
100470747000-417-430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.09.00.00.0%0.09.00.00.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%4.05.00.044.4%4.05.00.044.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.09.00.0%0.00.09.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%4.05.00.044.4%4.05.00.044.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Adial Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1260.1260%-0.036+129%-0.011+109%0.071+78%
Book Value Per Share--0.6370.6370%0.511+25%0.687-7%0.442+44%
Current Ratio--4.8984.8980%2.669+84%5.517-11%5.581-12%
Debt To Asset Ratio--0.1380.1380%0.428-68%0.288-52%3.700-96%
Debt To Equity Ratio--0.1600.1600%0.750-79%0.499-68%0.320-50%
Dividend Per Share----0%-0%-0%-0%
Eps---1.093-1.0930%-1.987+82%-1.831+68%-1.260+15%
Free Cash Flow Per Share---1.063-1.0630%-1.746+64%-1.373+29%-0.828-22%
Free Cash Flow To Equity Per Share---0.418-0.4180%-0.322-23%-0.069-83%0.021-2134%
Gross Profit Margin--1.0001.0000%1.000+0%1.000+0%1.000+0%
Intrinsic Value_10Y_max---9.785--------
Intrinsic Value_10Y_min---16.464--------
Intrinsic Value_1Y_max---1.291--------
Intrinsic Value_1Y_min---1.600--------
Intrinsic Value_3Y_max---3.643--------
Intrinsic Value_3Y_min---4.879--------
Intrinsic Value_5Y_max---5.709--------
Intrinsic Value_5Y_min---8.211--------
Market Cap6854184.600-74%11914750.80011914750.8000%1377242.700+765%11383071.060+5%9968105.433+20%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio1.678-74%2.9182.9180%0.420+594%2.633+11%2.283+28%
Pe Ratio-0.979+42%-1.702-1.7020%-0.108-94%-1.099-35%-0.924-46%
Price Per Share1.070-74%1.8601.8600%0.215+765%1.777+5%1.556+20%
Price To Free Cash Flow Ratio-1.007+42%-1.750-1.7500%-0.123-93%-1.435-18%-2.256+29%
Price To Total Gains Ratio8.493-74%14.76414.7640%-5.954+140%-5.017+134%-3.176+122%
Quick Ratio--4.3294.3290%2.235+94%4.857-11%4.760-9%
Return On Assets---1.478-1.4780%-2.221+50%-1.879+27%-5.712+286%
Return On Equity---1.715-1.7150%-3.886+127%-3.013+76%-2.522+47%
Total Gains Per Share--0.1260.1260%-0.036+129%-0.011+109%0.071+78%
Usd Book Value--4083529.0004083529.0000%3276494.000+25%4398897.200-7%2833099.556+44%
Usd Book Value Change Per Share--0.1260.1260%-0.036+129%-0.011+109%0.071+78%
Usd Book Value Per Share--0.6370.6370%0.511+25%0.687-7%0.442+44%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.093-1.0930%-1.987+82%-1.831+68%-1.260+15%
Usd Free Cash Flow---6806809.000-6806809.0000%-11185985.000+64%-8795720.600+29%-5301273.111-22%
Usd Free Cash Flow Per Share---1.063-1.0630%-1.746+64%-1.373+29%-0.828-22%
Usd Free Cash Flow To Equity Per Share---0.418-0.4180%-0.322-23%-0.069-83%0.021-2134%
Usd Market Cap6854184.600-74%11914750.80011914750.8000%1377242.700+765%11383071.060+5%9968105.433+20%
Usd Price Per Share1.070-74%1.8601.8600%0.215+765%1.777+5%1.556+20%
Usd Profit---7001890.000-7001890.0000%-12731416.000+82%-11721711.200+67%-8068620.333+15%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share--0.1260.1260%-0.036+129%-0.011+109%0.071+78%
 EOD+2 -6MRQTTM+0 -0YOY+26 -45Y+21 -910Y+20 -10

3.3 Fundamental Score

Let's check the fundamental score of Adial Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.979
Price to Book Ratio (EOD)Between0-11.678
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.329
Current Ratio (MRQ)Greater than14.898
Debt to Asset Ratio (MRQ)Less than10.138
Debt to Equity Ratio (MRQ)Less than10.160
Return on Equity (MRQ)Greater than0.15-1.715
Return on Assets (MRQ)Greater than0.05-1.478
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Adial Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.075
Ma 20Greater thanMa 501.022
Ma 50Greater thanMa 1001.015
Ma 100Greater thanMa 2001.026
OpenGreater thanClose1.000
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Adial Pharmaceuticals Inc

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.

Fundamental data was last updated by Penke on 2024-11-14 09:09:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Adial Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Adial Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Adial Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--112.2%+112.2%
TTM--221.4%+221.4%
YOY--210.0%+210.0%
5Y--342.2%+342.2%
10Y--464.5%+464.5%
4.3.1.2. Return on Assets

Shows how efficient Adial Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Adial Pharmaceuticals Inc to the Biotechnology industry mean.
  • -147.8% Return on Assets means that Adial Pharmaceuticals Inc generated $-1.48 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Adial Pharmaceuticals Inc:

  • The MRQ is -147.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -147.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-147.8%TTM-147.8%0.0%
TTM-147.8%YOY-222.1%+74.3%
TTM-147.8%5Y-187.9%+40.1%
5Y-187.9%10Y-571.2%+383.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-147.8%-11.3%-136.5%
TTM-147.8%-11.7%-136.1%
YOY-222.1%-11.3%-210.8%
5Y-187.9%-12.7%-175.2%
10Y-571.2%-14.1%-557.1%
4.3.1.3. Return on Equity

Shows how efficient Adial Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Adial Pharmaceuticals Inc to the Biotechnology industry mean.
  • -171.5% Return on Equity means Adial Pharmaceuticals Inc generated $-1.71 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Adial Pharmaceuticals Inc:

  • The MRQ is -171.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -171.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-171.5%TTM-171.5%0.0%
TTM-171.5%YOY-388.6%+217.1%
TTM-171.5%5Y-301.3%+129.8%
5Y-301.3%10Y-252.2%-49.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-171.5%-14.2%-157.3%
TTM-171.5%-15.9%-155.6%
YOY-388.6%-14.3%-374.3%
5Y-301.3%-18.5%-282.8%
10Y-252.2%-19.3%-232.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Adial Pharmaceuticals Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Adial Pharmaceuticals Inc is operating .

  • Measures how much profit Adial Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Adial Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Adial Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--222.9%+222.9%
TTM--310.7%+310.7%
YOY--223.5%+223.5%
5Y--387.1%+387.1%
10Y--498.5%+498.5%
4.3.2.2. Operating Ratio

Measures how efficient Adial Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Adial Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.465-2.465
TTM-3.253-3.253
YOY-3.298-3.298
5Y-4.788-4.788
10Y-6.494-6.494
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Adial Pharmaceuticals Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Adial Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.90 means the company has $4.90 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Adial Pharmaceuticals Inc:

  • The MRQ is 4.898. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.898. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.898TTM4.8980.000
TTM4.898YOY2.669+2.229
TTM4.8985Y5.517-0.620
5Y5.51710Y5.581-0.064
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8983.637+1.261
TTM4.8983.890+1.008
YOY2.6694.666-1.997
5Y5.5175.953-0.436
10Y5.5816.277-0.696
4.4.3.2. Quick Ratio

Measures if Adial Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Adial Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 4.33 means the company can pay off $4.33 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Adial Pharmaceuticals Inc:

  • The MRQ is 4.329. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.329. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.329TTM4.3290.000
TTM4.329YOY2.235+2.094
TTM4.3295Y4.857-0.528
5Y4.85710Y4.760+0.097
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3293.086+1.243
TTM4.3293.451+0.878
YOY2.2354.456-2.221
5Y4.8575.931-1.074
10Y4.7606.436-1.676
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Adial Pharmaceuticals Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Adial Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Adial Pharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.14 means that Adial Pharmaceuticals Inc assets are financed with 13.8% credit (debt) and the remaining percentage (100% - 13.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Adial Pharmaceuticals Inc:

  • The MRQ is 0.138. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.138. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.138TTM0.1380.000
TTM0.138YOY0.428-0.291
TTM0.1385Y0.288-0.150
5Y0.28810Y3.700-3.412
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1380.350-0.212
TTM0.1380.344-0.206
YOY0.4280.310+0.118
5Y0.2880.365-0.077
10Y3.7000.382+3.318
4.5.4.2. Debt to Equity Ratio

Measures if Adial Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Adial Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 16.0% means that company has $0.16 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Adial Pharmaceuticals Inc:

  • The MRQ is 0.160. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.160. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.160TTM0.1600.000
TTM0.160YOY0.750-0.590
TTM0.1605Y0.499-0.339
5Y0.49910Y0.320+0.179
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1600.394-0.234
TTM0.1600.432-0.272
YOY0.7500.380+0.370
5Y0.4990.451+0.048
10Y0.3200.490-0.170
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Adial Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Adial Pharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of -1.70 means the investor is paying $-1.70 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Adial Pharmaceuticals Inc:

  • The EOD is -0.979. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.702. Based on the earnings, the company is expensive. -2
  • The TTM is -1.702. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.979MRQ-1.702+0.723
MRQ-1.702TTM-1.7020.000
TTM-1.702YOY-0.108-1.593
TTM-1.7025Y-1.099-0.602
5Y-1.09910Y-0.924-0.175
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.979-2.303+1.324
MRQ-1.702-2.403+0.701
TTM-1.702-3.148+1.446
YOY-0.108-3.251+3.143
5Y-1.099-6.084+4.985
10Y-0.924-6.764+5.840
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Adial Pharmaceuticals Inc:

  • The EOD is -1.007. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.750. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.750. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.007MRQ-1.750+0.743
MRQ-1.750TTM-1.7500.000
TTM-1.750YOY-0.123-1.627
TTM-1.7505Y-1.435-0.315
5Y-1.43510Y-2.256+0.821
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.007-3.042+2.035
MRQ-1.750-3.234+1.484
TTM-1.750-3.719+1.969
YOY-0.123-4.557+4.434
5Y-1.435-8.332+6.897
10Y-2.256-9.276+7.020
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Adial Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.92 means the investor is paying $2.92 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Adial Pharmaceuticals Inc:

  • The EOD is 1.678. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.918. Based on the equity, the company is underpriced. +1
  • The TTM is 2.918. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.678MRQ2.918-1.239
MRQ2.918TTM2.9180.000
TTM2.918YOY0.420+2.497
TTM2.9185Y2.633+0.285
5Y2.63310Y2.283+0.349
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.6781.943-0.265
MRQ2.9182.051+0.867
TTM2.9182.356+0.562
YOY0.4202.454-2.034
5Y2.6333.714-1.081
10Y2.2834.378-2.095
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Adial Pharmaceuticals Inc.

4.8.1. Institutions holding Adial Pharmaceuticals Inc

Institutions are holding 4.279% of the shares of Adial Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30UBS Group AG1.3051083605778791360.0943
2024-06-30Manchester Capital Management LLC0.75080.00664809700
2024-06-30Renaissance Technologies Corp0.53620.000134346-16754-32.7867
2024-06-30HRT FINANCIAL LLC0.45630.000229228-6539-18.2822
2024-06-30BlackRock Inc0.433502777020131263.5293
2024-06-30Geode Capital Management, LLC0.4039025874258740
2024-06-30Citadel Advisors Llc0.3863024746247460
2024-06-30Tower Research Capital LLC0.08790.00015632100721.773
2024-06-301620 Investment Advisors Inc0.05620.0032360036000
2024-06-30Bank of America Corp0.010806896890
2024-06-30Morgan Stanley - Brokerage Accounts0.001207848160
2024-06-30Benjamin F. Edwards & Company, Llc0.000604000
2024-06-30Abound Wealth Management0.000402700
2024-06-30Royal Bank of Canada0.000301900
2024-06-30Qube Research & Technologies0.00010800
2024-06-30Wells Fargo & Co000-11-100
2024-06-30Headlands Technologies LLC000-64-100
2024-06-30Virtu Financial LLC000-20469-100
2024-06-30Advisor Group Holdings, Inc.000-2500-100
Total 4.42960.0102283759+107637+37.9%

4.9.2. Funds holding Adial Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Fidelity Extended Market Index0.56080.0001359261281455.4431
2024-09-30BlackRock Extended Equity Market K0.27430.000117572-7-0.0398
2024-09-30Vanguard Institutional Extnd Mkt Idx Tr0.14610935900
2024-09-30Fidelity Series Total Market Index0.1306083697412774.5037
2024-09-30Extended Equity Market Fund M0.03480.00012230-6-0.2683
2024-09-30Fidelity Nasdaq Composite Index0.0103066100
2024-09-30NT Ext Equity Mkt Idx Fd - L0.0093059800
2024-09-30Northern Trust Extended Eq Market Idx0.0093059800
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.0081052000
2024-09-30Fidelity Total Market Index0.008051000
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.0065041910.2392
2024-10-31State St US Extended Mkt Indx NL Cl C0.0048030800
2024-06-30SSgA U.S. Total Market Index Strategy0.00201263741.573
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.001409200
2024-10-31State St US Ttl Mkt Indx SL Cl I0.001408800
2024-09-30Northern Trust Wilshire 50000.000805200
Total 1.20850.000377428+20251+26.2%

5.3. Insider Transactions

Insiders are holding 1.799% of the shares of Adial Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-29Kevin SchuylerBUY7002.74
2021-11-29William B Stilley IiiBUY40064.75
2021-11-26James W Jr. NewmanBUY40071.25
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets4,737
Total Liabilities653
Total Stockholder Equity4,084
 As reported
Total Liabilities 653
Total Stockholder Equity+ 4,084
Total Assets = 4,737

Assets

Total Assets4,737
Total Current Assets3,199
Long-term Assets1,538
Total Current Assets
Cash And Cash Equivalents 2,827
Other Current Assets 372
Total Current Assets  (as reported)3,199
Total Current Assets  (calculated)3,199
+/-0
Long-term Assets
Property Plant Equipment -1,534
Intangible Assets 4
Long-term Assets Other 1,534
Long-term Assets  (as reported)1,538
Long-term Assets  (calculated)3
+/- 1,534

Liabilities & Shareholders' Equity

Total Current Liabilities653
Long-term Liabilities0
Total Stockholder Equity4,084
Total Current Liabilities
Accounts payable 127
Other Current Liabilities 526
Total Current Liabilities  (as reported)653
Total Current Liabilities  (calculated)653
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/- 0
Total Stockholder Equity
Common Stock2
Retained Earnings -68,798
Other Stockholders Equity 72,880
Total Stockholder Equity (as reported)4,084
Total Stockholder Equity (calculated)4,084
+/-0
Other
Cash and Short Term Investments 2,827
Common Stock Shares Outstanding 1,425
Liabilities and Stockholders Equity 4,737
Net Debt -2,827
Net Working Capital 2,546



5.2. Balance Sheets Structured

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
216
152
35
4,699
7,680
5,491
7,475
5,733
4,737
4,7375,7337,4755,4917,6804,69935152216
   > Total Current Assets 
206
141
27
4,693
7,673
5,136
6,462
4,780
3,199
3,1994,7806,4625,1367,6734,69327141206
       Cash And Cash Equivalents 
162
88
18
3,869
6,777
4,401
6,062
4,002
2,827
2,8274,0026,0624,4016,7773,8691888162
       Net Receivables 
0
35
0
0
0
0
0
0
0
0000000350
       Other Current Assets 
43
18
9
318
359
502
390
349
372
37234939050235931891843
   > Long-term Assets 
11
10
7
7
6
356
1,013
953
1,538
1,5389531,0133566771011
       Property Plant Equipment 
0
0
0
0
0
0
304
244
-1,534
-1,534244304000000
       Goodwill 
0
0
0
0
0
0
249
249
0
0249249000000
       Intangible Assets 
8
8
7
7
6
6
460
459
4
4459460667788
       Other Assets 
2
2
0
0
0
350
0
0
0
00035000022
> Total Liabilities 
53
255
1,032
258
539
1,505
3,967
2,456
653
6532,4563,9671,5055392581,03225553
   > Total Current Liabilities 
53
255
1,032
258
539
1,505
2,722
1,791
653
6531,7912,7221,5055392581,03225553
       Short-term Debt 
16
234
689
0
0
0
50
57
0
0575000068923416
       Short Long Term Debt 
0
234
689
0
0
0
0
0
0
0000006892340
       Accounts payable 
37
20
342
258
190
649
286
394
127
1273942866491902583422037
       Other Current Liabilities 
16
1
1
0
349
857
10
1,340
526
5261,3401085734901116
   > Long-term Liabilities 
0
0
0
0
190
649
1,245
665
0
06651,2456491900000
       Other Liabilities 
0
0
0
0
0
0
1,037
0
0
001,037000000
> Total Stockholder Equity
163
-103
-998
4,441
7,141
3,986
3,508
3,276
4,084
4,0843,2763,5083,9867,1414,441-998-103163
   Retained Earnings -68,798-63,675-50,943-31,520-20,627-12,035-404-9,938-9,518
   Accumulated Other Comprehensive Income 000000000
   Capital Surplus 
9,681
9,831
-597
16,470
27,757
35,491
0
0
0
00035,49127,75716,470-5979,8319,681
   Treasury Stock000000000



5.3. Balance Sheets

All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-1
Gross Profit-1-1
 
Operating Income (+$)
Gross Profit-1
Operating Expense-7,072
Operating Income-6,888-7,072
 
Operating Expense (+$)
Research Development1,267
Selling General Administrative5,621
Selling And Marketing Expenses1
Operating Expense7,0726,889
 
Net Interest Income (+$)
Interest Income106
Interest Expense-0
Other Finance Cost-0
Net Interest Income106
 
Pretax Income (+$)
Operating Income-6,888
Net Interest Income106
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,002-6,774
EBIT - interestExpense = -6,888
-8,880
-7,002
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-6,888-7,002
Earnings Before Interest and Taxes (EBITDA)-6,887
 
After tax Income (+$)
Income Before Tax-7,002
Tax Provision--1
Net Income From Continuing Ops-9,582-7,001
Net Income-7,002
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses7,072
Total Other Income/Expenses Net-114-106
 

Technical Analysis of Adial Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Adial Pharmaceuticals Inc. The general trend of Adial Pharmaceuticals Inc is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Adial Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Adial Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.18 < 1.28 < 1.92.

The bearish price targets are: 0.9696 > 0.9355 > 0.93.

Tweet this
Adial Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Adial Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Adial Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Adial Pharmaceuticals Inc. The current macd is -0.00510696.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Adial Pharmaceuticals Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Adial Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Adial Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Adial Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartAdial Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Adial Pharmaceuticals Inc. The current adx is 25.28.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Adial Pharmaceuticals Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Adial Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Adial Pharmaceuticals Inc. The current sar is 1.20664094.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Adial Pharmaceuticals Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Adial Pharmaceuticals Inc. The current rsi is 50.08. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Adial Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartAdial Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Adial Pharmaceuticals Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Adial Pharmaceuticals Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Adial Pharmaceuticals Inc Daily Stochastic Oscillator ChartAdial Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Adial Pharmaceuticals Inc. The current cci is 0.68091545.

Adial Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartAdial Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Adial Pharmaceuticals Inc. The current cmo is 1.69560669.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Adial Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartAdial Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Adial Pharmaceuticals Inc. The current willr is -86.66666667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Adial Pharmaceuticals Inc Daily Williams %R ChartAdial Pharmaceuticals Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Adial Pharmaceuticals Inc.

Adial Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Adial Pharmaceuticals Inc. The current atr is 0.05280873.

Adial Pharmaceuticals Inc Daily Average True Range (ATR) ChartAdial Pharmaceuticals Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Adial Pharmaceuticals Inc. The current obv is 508,951,744.

Adial Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartAdial Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Adial Pharmaceuticals Inc. The current mfi is 65.46.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Adial Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartAdial Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Adial Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-09MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Adial Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Adial Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.075
Ma 20Greater thanMa 501.022
Ma 50Greater thanMa 1001.015
Ma 100Greater thanMa 2001.026
OpenGreater thanClose1.000
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Adial Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Adial Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Adial Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Adial Pharmaceuticals Inc

I send you an email if I find something interesting about Adial Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Adial Pharmaceuticals Inc.

Receive notifications about Adial Pharmaceuticals Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.